Company Update: Amgen

Amgen Inc.  (AMGN)

We are pleased to share some good news about Amgen's use of fetal or embryonic stem cells.  After our repeated calls and emails to Amgen, they have verified that they do not currently utilize fetal or embryonic stem cell research in the development of their current product line.  

We will continue to monitor Amgen and other companies in the industry and will seek to engage them on any future plans to use embryonic or fetal stem cell research.